Nanalysis Scientific (CVE:NSCI) Trading 14.9% Higher

Shares of Nanalysis Scientific Corp. (CVE:NSCI) rose 14.9% during trading on Monday . The stock traded as high as C$0.43 and last traded at C$0.43. Approximately 127,038 shares traded hands during mid-day trading, an increase of 104% from the average daily volume of 62,412 shares. The stock had previously closed at C$0.37.

Nanalysis Scientific Stock Up 7.1 %

The company has a market cap of C$50.64 million, a PE ratio of -2.65 and a beta of 0.82. The company’s 50 day moving average is C$0.43 and its 200 day moving average is C$0.43. The company has a current ratio of 1.52, a quick ratio of 1.11 and a debt-to-equity ratio of 71.36.

Insider Buying and Selling

In other Nanalysis Scientific news, Director Michal Okoniewski purchased 80,000 shares of Nanalysis Scientific stock in a transaction dated Monday, March 18th. The stock was acquired at an average price of C$0.38 per share, for a total transaction of C$30,400.00. 7.11% of the stock is currently owned by insiders.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.